# A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine

> **NCT00002263** · NA · COMPLETED · sponsor: **Sandoz**

## Conditions studied

- HIV Infections
- Cytopenias

## Interventions

- **DRUG:** Zidovudine
- **DRUG:** Sargramostim

## Key facts

- **NCT ID:** NCT00002263
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002263, "A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00002263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*